Phibro Animal Health (PAHC) Stock May Still Offer Value At This Price
Published . Updated .
This report is about Health.
Directly affected
- PAHC Phibro Animal Health
Named in this report.
Indirectly affected
- XLV Health Care Select Sector SPDR
A fund of health-care companies
- XBI SPDR S&P Biotech
A fund of biotechnology companies
- UNH UnitedHealth+10.8%
A large health insurer
- JNJ Johnson & Johnson+0.5%
A large health-care company
- LLY Eli Lilly+14.8%
A large drug maker
- PFE Pfizer+9.7%
A large drug maker
Price reaction, T-5 to T+3
| Ticker | T-5 | T-3 | T-1 | T0 | T+1 | T+2 | T+3 |
|---|---|---|---|---|---|---|---|
| PAHC | +1.16% | +1.11% | base | after close | after close | after close | after close |
| XLV | -2.01% | -0.19% | base | after close | after close | after close | after close |
| XBI | -1.12% | +2.16% | base | after close | after close | after close | after close |
| UNH | -2.66% | -0.29% | base | after close | after close | after close | after close |
| JNJ | -3.73% | -2.35% | base | after close | after close | after close | after close |
| LLY | -2.64% | -0.26% | base | after close | after close | after close | after close |
| PFE | -1.93% | -0.50% | base | after close | after close | after close | after close |
Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.
Market Call
Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.
Phibro Animal Health (PAHC) Stock May Still Offer Value At This Price Yahoo Finance
Source: Yahoo Finance
This story
| Company | When | Move | Status |
|---|---|---|---|
| JNJ | three days earlier | -2.35% | final price |
| JNJ | five days earlier | -3.73% | final price |
| LLY | three days earlier | -0.26% | final price |
| LLY | five days earlier | -2.64% | final price |
| PAHC | three days earlier | +1.11% | final price |
| PAHC | five days earlier | +1.16% | final price |
| PFE | three days earlier | -0.50% | final price |
| PFE | five days earlier | -1.93% | final price |
| UNH | three days earlier | -0.29% | final price |
| UNH | five days earlier | -2.66% | final price |
| XBI | three days earlier | +2.16% | final price |
| XBI | five days earlier | -1.12% | final price |
| XLV | three days earlier | -0.19% | final price |
| XLV | five days earlier | -2.01% | final price |
Trades by members of Congress and officials in the stocks in this story
- Rep. Maria Elvira Salazar sold Unitedhealth Group (UNH), worth $1,001 - $15,000 on 24 Sep 2026. That is 30 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Kevin Hern sold Unitedhealth Group (UNH) (jointly held), worth $15,001 - $50,000 on 23 Sep 2026. That is 31 days before publication. Filed 13 Oct 2026. View the filing.
- Rep. Kevin Hern sold Unitedhealth Group (UNH) (jointly held), worth $15,001 - $50,000 on 10 Sep 2026. That is 44 days before publication. Filed 25 Sep 2026. View the filing.
- Rep. Rohit Khanna bought Johnson & Johnson (JNJ) (held by a spouse), worth $1,001 - $15,000 on 25 Sep 2026. That is 29 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Lloyd Doggett bought Johnson & Johnson (JNJ), worth $1,001 - $15,000 on 8 Sep 2026. That is 46 days before publication. Filed 5 Oct 2026. View the filing.
- Rep. Rohit Khanna bought Johnson & Johnson (JNJ) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 50 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Rohit Khanna bought Eli Lilly (LLY) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 50 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Rohit Khanna sold Pfizer (PFE) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 50 days before publication. Filed 7 Oct 2026. View the filing.
- Donald J Trump, an executive branch official, bought Pfizer (PFE), worth $100,001 - $250,000 on 31 Jul 2026. That is 85 days before publication. Filed 22 Sep 2026. View the filing.
Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).
This story
12 out of 100
“Phibro Animal Health (PAHC) Stock May Still Offer Value At This Price” scores 12 out of 100. The score uses 1 sources.